Small molecule combats cancer-causing KRAS protein at last

Roy S. Herbst () and Joseph Schlessinger

Nature, 2019, vol. 575, issue 7782, 294-295

Abstract: A molecule has now been characterized that acts to inhibit a cancer-causing form of KRAS protein and stimulate the immune system. The inhibitor is one of the first of its kind to show anticancer activity in the clinic.

Keywords: Medical research; Cancer; Immunology (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-03242-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:575:y:2019:i:7782:d:10.1038_d41586-019-03242-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-03242-8

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().